Literature DB >> 22865287

Long-term effects of injection laryngoplasty with a temporary agent on voice quality and vocal fold position.

Brandon L Prendes1, Katherine C Yung, Ilya Likhterov, Sarah L Schneider, Soha A Al-Jurf, Mark S Courey.   

Abstract

OBJECTIVES/HYPOTHESIS: Patients with unilateral vocal fold paralysis (UVFP) treated with temporary injection laryngoplasty (IL) have a decreased rate of permanent medialization laryngoplasty (ML) compared to UVFP patients initially treated by observation. The aim of this study was to determine whether the lower rate of ML corresponded with improved quantifiable measures. STUDY
DESIGN: Retrospective review.
METHODS: Examinations at presentation and follow-up of 14 IL patients and 24 observation patients were analyzed for laryngoscopic features and Consensus Auditory-Perceptual Evaluation of Voice (CAPE-V) scores.
RESULTS: The groups were similar at presentation. At follow-up, the IL group showed significant improvement in 11/18 laryngoscopic criteria and 7/12 CAPE-V parameters compared to the observation group (P < .05). The observation group underwent ML more frequently than the IL group (75% vs. 29%, P = .008).
CONCLUSIONS: The lower rate of permanent ML in patients undergoing temporary IL corresponds with improvements in CAPE-V scores and laryngoscopic features. Improvements persisted beyond the accepted time frame for temporary graft resorption.
Copyright © 2012 The American Laryngological, Rhinological, and Otological Society, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22865287     DOI: 10.1002/lary.23473

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  8 in total

Review 1.  [Glottis injection to improve voice function : Review of more than 500 operations].

Authors:  M Tigges; M Hess
Journal:  HNO       Date:  2015-07       Impact factor: 1.284

2.  The surgical treatment of unilateral vocal cord paralysis (UVCP): qualitative review analysis and meta-analysis study.

Authors:  F Granato; F Martelli; L V Comini; P Luparello; S Coscarelli; O Le Seac; S Carucci; P Graziani; R Santoro; G Alderotti; M R Barillari; Giuditta Mannelli
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-08-02       Impact factor: 2.503

Review 3.  Voice outcome indicators for unilateral vocal fold paralysis surgery: a review of the literature.

Authors:  G Desuter; M Dedry; B Schaar; J van Lith-Bijl; P P van Benthem; E V Sjögren
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-12-20       Impact factor: 2.503

4.  Chronic vocal cord palsy in Thuringia, Germany: a population-based study on epidemiology and outcome.

Authors:  S Djugai; D Boeger; J Buentzel; D Esser; K Hoffmann; P Jecker; A Mueller; G Radtke; S Bohne; M Finkensieper; G F Volk; O Guntinas-Lichius
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-08-22       Impact factor: 2.503

5.  Dynamics of rectal balloon implant shrinkage in prostate VMAT : Influence on anorectal dose and late rectal complication risk.

Authors:  Ben G L Vanneste; Y van Wijk; L C Lutgens; E J Van Limbergen; E N van Lin; K van de Beek; P Lambin; A L Hoffmann
Journal:  Strahlenther Onkol       Date:  2017-10-16       Impact factor: 3.621

6.  Using Innovative Acoustic Analysis to Predict the Postoperative Outcomes of Unilateral Vocal Fold Paralysis.

Authors:  Yung-An Tsou; Yi-Wen Liu; Wen-Dien Chang; Wei-Chen Chen; Hsiang-Chun Ke; Wen-Yang Lin; Hsing-Rong Yang; Dung-Yun Shie; Ming-Hsui Tsai
Journal:  Biomed Res Int       Date:  2016-09-21       Impact factor: 3.411

7.  Medialization thyroplasty versus injection laryngoplasty: a cost minimization analysis.

Authors:  Samantha Tam; Hongmei Sun; Sisira Sarma; Jennifer Siu; Kevin Fung; Leigh Sowerby
Journal:  J Otolaryngol Head Neck Surg       Date:  2017-02-20

8.  Office-Based Intracordal Hyaluronate Injections Improve Quality of Life in Thoracic-Surgery-Related Unilateral Vocal Fold Paralysis.

Authors:  Tuan-Jen Fang; Li-Jen Hsin; Hsiu-Feng Chung; Hui-Chen Chiang; Hsueh-Yu Li; Alice M K Wong; Yu-Chen Pei
Journal:  Medicine (Baltimore)       Date:  2015-10       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.